Viewing StudyNCT00242567



Ignite Creation Date: 2024-05-05 @ 12:07 PM
Last Modification Date: 2024-10-26 @ 9:20 AM
Study NCT ID: NCT00242567
Status: COMPLETED
Last Update Posted: 2014-05-07
First Post: 2005-10-19

Brief Title: Study of Zoledronic Acid for Patients With Hormone-sensitive Bone Metastases From Prostate Cancer
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Prostate Cancer
Keywords:
Name View
hormone-sensitive View
zoledronic acid View
bone metastases View
prostate cancer View